Joining forces with academic and clinical partners to develop novel technologies for neurological disorders.
A new model of interdisciplinary cooperation
The Campus Biotech Lighthouse Partnership for AI-Guided Neuromodulation is a groundbreaking inter-institutional collaboration aimed at accelerating translational research and development in the field of neurotechnology and artificial intelligence. The goal of the initiative is to leverage interdisciplinary excellence present in the Lemanic Region to further innovate and accelerate novel cutting-edge neurotechnologies to treat neurological and mental health disorders.
The Wyss Center has committed to provide CHF 18M funding over four years to accelerate translational technologies.
Partners
Tackling a growing public health threat
The impact of deaths and disability caused by neurological disorders is increasingly being recognized as a global public health challenge, and this burden is set to rise during the next few decades as a result of an aging population. Around 165 million Europeans are living with a brain disorder, and it is estimated that one in three people will suffer from a neurological and/or mental disorder at some point in their lives. Novel treatments using recent advances in artificial intelligence, neuroscience and neurotechnology are urgently needed to address this challenge.
Current projects led by the Lighthouse Partnership
Restoration of movement for spinal cord injuries
Leveraging AI to enable precision treatments of mental diseases
Opsonins to release spasticity in paralyzed patients
“As a research institute exploring breakthrough neurotechnologies across a wide spectrum of potential use cases, EPFL is looking forward to the unique translational capabilities of the Wyss Center to advance our most mature technologies into the clinic.”
“UNIGE with its world-class neuroscience researchers is proud to be a partner of the Wyss Center to raise the position of neuroscience and neurotechnology in Western Switzerland.”
“By combining artificial intelligence and novel neuromodulation techniques, we aim to target deep brain structures non-invasively, advance a brain-spine interface for paralysis, and innovate peripheral nerve therapies.”
“The Lighthouse Partnership exemplifies the Wyss Center’s mission to innovate and accelerate promising technologies to improve the lives of people suffering from neurological and mental health disorders.”
Related updates
Guiding Innovation: Celebrating the Lighthouse Partnership’s Successful First Year
In Conversation with Tom Hutson, PhD, Group Leader
